Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia
This study is ongoing, but not recruiting participants.
Study NCT00052299 Information provided by National Cancer Institute (NCI)
First Received: January 24, 2003 Last Updated: July 23, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia
Additional conditions recognized in this trial
Leukemia, Myeloid
Leukemia, Myeloid, Acute
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
cytarabine
etoposide
gemtuzumab ozogamicin
idarubicin
mitoxantrone hydrochloride
Additional drug interventions recognized in this trial
Antibodies, Monoclonal
Gemtuzumab
Mitoxantrone
More general drug interventions related to this trial
Analgesics
Anti-Infective Agents
Antibiotics, Antineoplastic
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Antiviral Agents
Central Nervous System Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
European Organization for Research and Treatment of Cancer
Gruppo Italiano Malattie EMatologiche dell'Adulto
Back to top of Main Content
